Spero Therapeutics, Inc. (SPRO): 8-K filed Jun 25, 2026

Form type

8-K

Filing date

Jun 25, 2026

Accession number

0001193125-26-283033

Filer

Spero Therapeutics, Inc. (CIK 1701108)